about
Hib Vaccines: Past, Present, and Future PerspectivesRoles and relevance of mast cells in infection and vaccinationEnhancing vaccine safety capacity globally: A lifecycle perspectiveSystems Biology Approach for Cancer Vaccine Development and EvaluationChallenges and future in vaccines, drug development, and immunomodulatory therapySearching for the human genetic factors standing in the way of universally effective vaccinesTrial watch: Dendritic cell-based anticancer therapyThe Capricious Nature of Bacterial Pathogens: Phasevarions and Vaccine DevelopmentRecent developments in clinical trial designs for HIV vaccine researchThe prevention and eradication of smallpox: a commentary on Sloane (1755) 'An account of inoculation'Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013Overview on the Current Status of Zika Virus Pathogenesis and Animal Related ResearchTechnological Microbiology: Development and ApplicationsComputational tools for epitope vaccine design and evaluationCapitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine designBeyond new chemical entities: advancing drug development based on functional versatility of antibodiesThe contribution of vaccination to global health: past, present and future.New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model.Dendritic-cell-based therapeutic cancer vaccinesNew challenges in modern vaccinologyInnate responses induced by whole inactivated virus or subunit influenza vaccines in cultured dendritic cells correlate with immune responses in vivo.Disruption of Type I Interferon Induction by HIV Infection of T Cells.Sex difference in immune response to vaccination: A participant-level meta-analysis of randomized trials of IMVAMUNE smallpox vaccineNew prospects for a preventive HIV-1 vaccine.Rhesus Macaque B-Cell Responses to an HIV-1 Trimer Vaccine Revealed by Unbiased Longitudinal Repertoire Analysis.Beyond antigens and adjuvants: formulating future vaccines.Global challenges keynote address in memoriam to colleagues lost in the Malaysia airlines 17 crashDevelopment of prophylactic vaccines against HIV-1.Immune focusing and enhanced neutralization induced by HIV-1 gp140 chemical cross-linking.Sustained antigen availability during germinal center initiation enhances antibody responses to vaccinationAccelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design.HIV Diagnosis and Treatment through Advanced Technologies.Human dendritic cell subsets in vaccination.Introducing new vaccines in developing countries.Discovery of protective B-cell epitopes for development of antimicrobial vaccines and antibody therapeutics.Human immunodeficiency virus antibodies and the vaccine problem.Directing the immune system with chemical compounds.Vaccine responsiveness in the elderly: best practice for the clinic.Challenges in mucosal vaccines for the control of infectious diseases.Candida antigens and immune responses: implications for a vaccine.
P2860
Q26767144-FC2236E7-B2A8-42E0-B88C-C74C3763C250Q26777264-F4AD44BB-E04F-4E28-90DD-4617708D756BQ26782451-25CEE494-2A82-4535-B28F-6AF72EB4CD6BQ26782580-E222B3C9-EEE1-47AB-91ED-34DDA210EAEFQ26853354-6EB4F682-C42D-408D-AC20-ED9388B21B98Q27007034-EC39FD6F-7513-49C1-B802-BF185BC76268Q27024047-10A0B497-48FD-40AB-B1F0-CCD186ECD480Q28074750-B00DF98F-2FF2-4A80-AFD8-3C0DF8F8D21FQ28083514-F4A1B0B4-C4D6-4708-A19A-E15F4FBE4570Q28088338-D1605F70-8F5F-4DCF-9A11-86547C92388EQ28654939-876A3C42-99E2-43DD-8ED6-19CFB6C17D92Q29994557-29CF779A-DB75-4C4C-AA9F-239F9B3A0BCDQ30250972-25BD62C5-8869-4E2B-9DDD-B6CC56B55035Q30373339-95ECACEE-ECA3-4343-97D5-D0B02CA5731DQ30374314-F5FF23F0-C522-4162-A5C5-94466BE4134EQ30386064-378862B6-A52D-4CBC-92D5-D1F6A2BF5142Q33624593-F6678FAE-7743-4E3E-B5DB-B34E7B474E44Q33868760-C40DAFFC-FFFA-4237-BC7D-A3CEF60C228AQ34360094-3587E941-04FB-4A83-A1C3-FB331638C484Q35218614-3FD66FAF-058D-4C41-B655-0C121499984DQ35560781-849324C9-A060-4C2D-8FCE-18055BEE9672Q35777137-B2255F69-83D4-4657-8F2C-BDD6159F5DE3Q36090390-5A73E883-6D98-4DB4-A2B7-ECB0C4F58D48Q36223864-FFD01089-C11C-4786-8127-758F271AD171Q36245216-D496FF58-F8D6-42D1-8473-8D27B9884B3FQ36618500-36A2F830-E973-409F-9DF3-AD0D8741C2B4Q36789620-29F9C6F1-E6B9-4681-BBB5-51FDE0576D41Q37042563-424351FD-9FE4-4089-A616-590806C7E03DQ37123168-C3DC5297-0303-48DC-8D93-A7BDA4CFD02EQ37379662-07A056C9-69FE-4DF1-9E24-9D2A638A96B4Q37615969-E3096997-8326-40FB-B837-58977038A067Q37683120-3C8D1F7E-709B-42C8-AACD-0C5A166936E6Q38110971-2BD820A5-B282-40B1-9B9B-A54C801DF123Q38160253-0602BEAB-5A64-40AF-8E42-47592753E866Q38161994-4AD42847-1BCB-44FC-9877-269F13E0D99EQ38192126-6D97E357-BA30-4215-A88A-71C2B7AEE28CQ38201155-C9A13C65-EFE0-4BAE-B68A-1A4E26069C13Q38217108-BC5DCA55-C13F-49F4-8C92-92454C7508B7Q38219010-8B5E1A8F-31FE-456D-A42D-6C3E8A7E7C51Q38222636-DDFFCEBF-AE4B-4EC4-85C0-F467A39420AE
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Designing tomorrow's vaccines.
@ast
Designing tomorrow's vaccines.
@en
type
label
Designing tomorrow's vaccines.
@ast
Designing tomorrow's vaccines.
@en
prefLabel
Designing tomorrow's vaccines.
@ast
Designing tomorrow's vaccines.
@en
P2860
P356
P1476
Designing tomorrow's vaccines.
@en
P2860
P304
P356
10.1056/NEJMRA1204186
P407
P50
P577
2013-02-01T00:00:00Z